Canary Regulatory Affairs

BEHIND A NAME THERE IS ALWAYS A STORY

Why Canary?

Patients and parents of children suffering from a disease for which there is no cure, physicians specialising in its treatment, and scientists who have spent a good part of their lives developing a promising therapy convene from all over the world to meet with the decision makers for a final review of the scientific evidence towards approval of a new treatment. At the end of the day a decision is made.

This scene repeated itself every day from 1995 to 2019 at Canary Wharf, London, then the site of the European Medicines Agency (EMA). We were part of this story and that location will always hold a special place in our memory. The sense of relief felt by all in knowing that hopeful patients will now be able to access a previously unavailable treatment is indescribable. The tears of joy are unforgettable.

Hence, Canary.

LOOKING FOR A REGULATORY AFFAIRS CONSULTANT